Key statistics

Is BMA a good stock to buy in 2026?

The BMA stock exhibits a premium valuation with a P/E ratio of 43.02x, significantly higher than the Banks – Regional sector average of 22.1x, indicating it is currently expensive relative to its peers. Furthermore, the discounted cash flow (DCF) analysis points to a fair value of $45.11, suggesting the stock is overvalued by 34.5% compared to its current price. Despite these valuation concerns, 42.9% of analysts maintain a ‘Buy’ rating for BMA, with a consensus price target of $130 offering a substantial 88.8% upside from current levels.

2026 BMA price scenarios

Based on analyst consensus of $130 from 14 analysts. Not a prediction by Alert Invest.

About Banco Macro S.A. (BMA)

Banco Macro S.A. provides various banking products and services to retail and corporate customers in Argentina. It offers various retail banking products and services, such as savings and checking accounts, time deposits, credit and debit cards, consumer finance loans, mortgage loans, automobile loans, overdrafts, credit-related services, home and car insurance coverage, tax collection, utility payments, automated teller machines (ATMs), and money transfers.

Led by CEO Juan Martin Parma, Banco Macro S.A. operates as a prominent regional bank in Argentina, employing approximately 9,004 individuals. The bank’s distinctive strengths lie in its extensive network and deep understanding of the local Argentine market, allowing it to cater effectively to both individual and corporate clients across a broad spectrum of financial needs.

BMA competitive moat and business analysis

Banco Macro S.A.’s competitive advantage, or moat, is primarily observed through its established presence and brand recognition in the Argentine financial landscape. While the net margin of 4.07% suggests a lean operation, fundamental profitability metrics like ROE and ROIC are currently not available (N/A), making a direct comparison to capital efficiency difficult. However, a solid market share and customer loyalty in its regional focus can contribute to a sustainable, albeit sometimes challenged, competitive edge against smaller players.

Regarding revenue breakdown, specific segments and geographical data for Banco Macro S.A. are currently unavailable. The company generates its $4.01 billion in total revenue (TTM) from a diversified range of banking products and services offered to retail and corporate clients within Argentina. This broad offering helps mitigate risk by not being overly reliant on a single product line or customer segment.

The moat trend for BMA stock appears challenging given the significant year-over-year revenue decline of -99.9%. This steep drop raises questions about the sustainability of its competitive advantages and its ability to defend market share or grow in the current environment. There is no public transcript quote available at this time to provide further context on management’s perspective regarding this substantial revenue change.

When assessing BMA against its peers in the Financial Services sector, it’s important to consider its unique regional focus within Argentina. Investors can gain a clearer perspective on BMA’s relative performance by examining detailed comparisons. For instance, prospective investors might consider exploring BMA vs AVAL, BMA vs COLB, or BMA vs FNB to benchmark BMA’s valuation, growth prospects, and financial health against other regional banks.

Banco Macro S.A. analyst rating

Based on 14 analysts. 42.9% rate BMA Buy or Strong Buy.

A 42.9% “Buy” rating for BMA stock, alongside an equal percentage of “Hold” ratings, indicates a moderately positive sentiment among analysts, which is generally considered reasonable for the Financial Services sector. While not a strong consensus, the significant upside to the target price often attracts attention.

Is BMA undervalued or overvalued?

When evaluating BMA valuation, its P/E ratio of 43.02x stands out significantly, more than double the Banks – Regional sector average of 22.1x. This substantial premium suggests that investors are currently paying a high price for BMA’s earnings, hinting at an overvalued BMA stock relative to its industry peers. This P/E disparity is a key factor for any investor considering whether BMA is a good stock to buy at its current levels.

Adding to the valuation narrative, the Discounted Cash Flow (DCF) model calculates a fair value for BMA stock at $45.11. This figure is notably lower than the current trading price, indicating a -34.5% downside and reinforcing the view that the stock may be overvalued. While the P/S ratio appears relatively cheap at 1.72x, the extremely high P/B ratio of 1920.9x further underscores the stretched valuation, contrasting sharply with the more favorable analyst consensus target of $130 which implies significant upside.

BMA financial health & key metrics

For value investors, assessing the financial health of BMA stock presents a mixed picture. While the company boasts a healthy debt-to-equity ratio of 0.29x and a fair FCF yield of 4.54%, indicating solid financial strength and cash generation, its valuation metrics are significantly elevated. The P/E ratio of 43.02x is considerably higher than the sector average, and the DCF fair value of $45.11 suggests the current BMA stock price is overvalued. Coupled with a concerning -99.9% revenue growth and low net margin, investors should exercise caution and conduct thorough due diligence beyond just the analyst targets.

Banco Macro S.A. earnings history & next report

Banco Macro S.A. reported EPS of $1.98, beating estimates by 43.48%. Next earnings: 2026-05-27 with EPS estimate of $1.42.

Investors tracking BMA stock should pay close attention to the upcoming earnings report on 2026-05-27, where the estimated EPS is $1.42. The previous quarter’s beat by 43.48% sets a high bar, and the market will be keenly watching to see if Banco Macro S.A. can continue this positive momentum or if the significant revenue decline reflected in other data points will impact profitability. The guidance provided by CEO Juan Martin Parma for future periods will be crucial in shaping the market’s perception of BMA valuation and its investment prospects.

BMA daily short volume

Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.

BMA insider trading activity

Corporate insiders must report trades to the SEC within two business days.

Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice

Recent BMA analyst rating changes

Banco Macro S.A. stock news today

How does BMA compare to its peers?

Understanding how BMA stock stacks up against its competitors in the Banks – Regional industry is crucial for a comprehensive investment analysis. While Banco Macro S.A. holds a unique position within the Argentine market, comparing its key metrics and business model to other regional banks can shed light on its relative strengths and weaknesses, especially concerning BMA valuation and growth prospects.

FAQ — Banco Macro S.A. (BMA) stock